 AUSTIN, Texas, Dec. 02, 2022 GLOBE NEWSWIRE Molecular Templates, Inc. Nasdaq: MTEM, Molecular Templates, or MTEM, a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies ETBs, today announced that they will present a poster on interim clinical results for the MT-5111 program at the San Antonio ... The post Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annua... 